---
title: Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung
  cancer
date: '2024-03-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38449616/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240307170638&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: TD resulting from PD-1/PD-L1 inhibitor treatment in advanced
  lung cancer may be associated with good clinical outcomes. The clarification of
  the molecular mechanisms underlying TD and the identification of reliable predictive
  biomarkers will guide clinicians in managing TD in this patient ...'
disable_comments: true
---
CONCLUSION: TD resulting from PD-1/PD-L1 inhibitor treatment in advanced lung cancer may be associated with good clinical outcomes. The clarification of the molecular mechanisms underlying TD and the identification of reliable predictive biomarkers will guide clinicians in managing TD in this patient ...